Integrated Proteomic and Metabolomic Profiling for Developing Novel Plasma‐Based Diagnostic Models of Sarcopenia

We have developed high-performance plasma-based diagnostic models for sarcopenia by integrating inflammatory proteomic and metabolomic signatures. A four-biomarker model (Combined Model 2) demonstrated excellent diagnostic performance and may provide a promising clinically scalable approach for the early detection of sarcopenia.